|
June 1, 2007
Cancer Management: A Multidisciplinary Approach, 10th Edition (2007).
Chapter 39
Depression, anxiety, and delirium
Alan Valentine, MD
Psychiatric disorders are common in the setting of malignant disease, occurring in almost 50% of patients. Many cancer patients cope well with their disease. For those who do not, untreated psychological and neuropsychiatric disorders can seriously compromise quality of life and treatment compliance. Although there is a wide variety of presentations, three behavioral syndromes that are often encountered in clinical practice will be discussed here: depression, anxiety, and delirium. Depression"Depression" exists on a continuum ranging from an emotion common in daily life (sadness) to a syndrome of severe physical and psychological symptoms consistent with a defined psychiatric disorder (major depressive disorder). In cancer patients, identical symptoms may be caused or influenced by physical (eg, tumor site, pain), psychological (eg, stress, premorbid function, maturity), and social (eg, finances, interpersonal relationships) factors. Depression occurs more frequently in the setting of severe illness; several studies of cancer inpatients report a prevalence of 25%–42%. SIGNS AND SYMPTOMS/DIAGNOSIS Patients with depressive syndromes experience specific symptoms that vary in intensity and severity. Psychological symptoms include dysphoria (sadness), anhedonia (pervasive loss of pleasure in activities), feelings of guilt or low self-esteem, and thoughts of death or suicide. Somatic symptoms include sleep disturbance, change in appetite, loss of libido, fatigue, diminished concentration, and psychomotor agitation or withdrawal. Focus of diagnostic evaluation Although the diagnosis of major depressive disorder requires that multiple symptoms (including dysphoria or anhedonia) must be present for at least 2 weeks, patients who do not meet these criteria may be in significant distress. The diagnosis of depression in medically ill patients is complicated by the fact that somatic symptoms of depression may also be caused by factors related to disease and treatment. For this reason, when evaluating the depressed cancer patient, special attention should be paid to psychological symptoms, which are less likely to be directly related to treatment. ETIOLOGY Psychological causesIsolated symptoms Isolated depressive symptoms, if temporally related to an identifiable stressor, may be classified as adjustment disorders. In the setting of malignancy, obvious stressors include the initial diagnosis, treatment failure, or disease progression. Patients may also face potential psychosocial stressors, including changes in independence, body image, finances, and family function, as well as issues related to death and dying. Persistent symptoms Persistent mood symptoms may indicate the presence of an evolving major depressive disorder. Major depressive disorder is common in the general population (point prevalence, ~6%) and is a recurrent disease. Patients with a history of mood disorder are at risk for relapse in the face of a cancer diagnosis. Disease- and treatment-related causesPresenting symptom of malignancy Depression may be a presenting symptom of some primary malignancies, including primary pancreatic and gastric carcinomas. Primary and metastatic brain tumors may cause frontal lobe syndromes or personality changes that mimic depression and other psychiatric disorders.
Table of Contents
Chapter 1: Principles of Surgical Oncology
Chapter 2: Principles of Radiation Therapy Chapter 3: Principles of Oncologic Pharmacotherapy Chapter 4: Head and Neck Tumors Chapter 5: Thyroid and Parathyroid Cancers Chapter 6: Non–Small-Cell Lung Cancer Chapter 7: SCLC, Mesothelioma, Thymoma Chapter 8: Breast Cancer Overview Chapter 9: Stages 0 and I Breast Cancer Chapter 10: Stage II Breast Cancer Chapter 11: Stage III Breast Cancer Chapter 12: Esophageal Cancer Chapter 13: Gastric Cancer Chapter 14: Pancreatic, Neuroendocrine GI, and Adrenal Cancers Chapter 15: Liver, Gall Bladder, and Biliary Tract Cancer Chapter 16: Colon, Rectal, and Anal Cancers Chapter 17: Prostate Cancer Chapter 18: Testicular Cancer Chapter 19: Urothelial and Kidney Cancers Chapter 20: Cervical Cancer Chapter 21: Uterine Corpus Tumors Chapter 22: Ovarian Cancer Chapter 23: Melanoma and Other Skin Cancers Chapter 24: Bone Sarcomas Chapter 25: Soft-tissue Sarcomas Chapter 26: Primary and Metastatic Brain Tumors Chapter 27: AIDS-related Malignancies Chapter 28: Carcinoma of an Unknown Primary Site Chapter 29: Hodgkin's Lymphoma Chapter 30: Non-Hodgkin's Lymphoma Chapter 31: Multiple Myeloma and Other Plasma Cell Dyscrasias Chapter 32: Acute Leukemias Chapter 33: Chronic Myelogenous Leukemia Chapter 34: Chronic Lymphocytic Leukemia Chapter 35: Myelodysplastic Syndromes Chapter 36: Hematopoietic Cell Transplantation Chapter 37: Pain Management Chapter 38: Management of Nausea and Vomiting Chapter 39: Depression, Anxiety, and Delirium Chapter 40: Hematopoietic Growth Factors Chapter 41: Fatigue and Dyspnea Chapter 42: Anorexia and Cachexia Chapter 43: Long-term Venous Access Chapter 44: Prevention and Management of Radiation Toxicity Chapter 45: Oncologic Emergencies Chapter 46: Infectious Complications Chapter 47: Fluid Complications Appendix 1: Performance Scales Appendix 2: Cancer Info on the Internet Appendix 3: Cancer Drugs and Indications Appendix 4: Chemotherapeutic Agents and Their Uses, Dosages, and Toxicites |
|